Top Markets
Coin of the day
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Clasificación en acciones #425
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health... Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Precio por acción
$116.80
Capitalización bursátil
$51.47B
Cambio (1 día)
0.75%
Cambio (1 año)
-27.59%
País
US
Comercio Zoetis Inc. (ZTS)

Categoría

Ratio P/E de Zoetis Inc. (ZTS)
Ratio P/E al March 2026 TTM: 18.95
Según los últimos informes financieros y el precio de las acciones de Zoetis Inc., el P/E actual (TTM) de la empresa es 18.95. Al final de 2023, la empresa tenía un P/E de 38.83.
Historial del ratio P/E de Zoetis Inc. desde 2009 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
2026 (TTM) 18.95 -36.33%
2024 29.77 -23.34%
2023 38.83 19.46%
2022 32.51 -42.80%
2021 56.83 18.28%
2020 48.04 13.88%
2019 42.19 45.79%
2018 28.94 -29.16%
2017 40.85 26.39%
2016 32.32 -54.24%
2015 70.64 91.00%
2014 36.98 14.03%
2013 32.43 -8.80%
2012 35.56 -41.24%
2011 60.52 -55.10%
2010 134.79 -190.91%
2009 -148.27 0.00%
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
17.97 -5.19%
DE
28.23 48.92%
FR
79.35 318.66%
JP
-0.65 -103.41%
IL
22.30 17.66%
GB
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.